Last update 01 Nov 2024

P53-SADA-BsAb

Overview

Basic Info

Drug Type
Bispecific antibody
Synonyms-
Target
GD2
Mechanism
GD2 inhibitors(Disialoganglioside GD2 inhibitors)
Therapeutic Areas
NeoplasmsRespiratory DiseasesSkin and Musculoskeletal Diseases
Active Indication
MelanomaSarcomaSmall Cell Lung Cancer
Inactive Indication-
Originator Organization
Y-mAbs Therapeutics, Inc.Y-mAbs Therapeutics, Inc.Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer CenterMassachusetts Institute of TechnologyMassachusetts Institute of Technology
Active Organization
Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer CenterY-mAbs Therapeutics, Inc.Y-mAbs Therapeutics, Inc.Massachusetts Institute of TechnologyMassachusetts Institute of Technology
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

100 Clinical Results associated with P53-SADA-BsAb
Login to view more data
100 Translational Medicine associated with P53-SADA-BsAb
Login to view more data
100 Patents (Medical) associated with P53-SADA-BsAb
Login to view more data
100 Deals associated with P53-SADA-BsAb
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
MelanomaPhase 1-
Massachusetts Institute of TechnologyMassachusetts Institute of Technology
-
MelanomaPhase 1-
Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer Center
-
MelanomaPhase 1-
Y-mAbs Therapeutics, Inc.Y-mAbs Therapeutics, Inc.
-
SarcomaPhase 1-
Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer Center
-
SarcomaPhase 1-
Y-mAbs Therapeutics, Inc.Y-mAbs Therapeutics, Inc.
-
SarcomaPhase 1-
Massachusetts Institute of TechnologyMassachusetts Institute of Technology
-
Small Cell Lung CancerPhase 1-
Massachusetts Institute of TechnologyMassachusetts Institute of Technology
-
Small Cell Lung CancerPhase 1-
Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer Center
-
Small Cell Lung CancerPhase 1-
Y-mAbs Therapeutics, Inc.Y-mAbs Therapeutics, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free